WASHINGTON UNIVERSITY SCHOOL OF MEDICINE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1891-01-01

Employees: 10K

Market Cap: -

Website: http://www.medschool.wustl.edu

Clinical Trials

Sinemet for Spasticity and Function in Amyotrophic Lateral Sclerosis and Primary Lateral Sclerosis

Phase 1

Completed

Conditions: Motor Neuron Disease
Amyotrophic Lateral Sclerosis

Interventions: Drug: carbidopa-levodopa
Drug: Placebo Oral Tablet

First Posted Date: 2019-04-26

Last Posted Date: 2022-07-11

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 15

Registration Number: NCT03929068

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Translation of Pritikin Program to the Community

Not Applicable

Completed

Conditions: Metabolic Syndrome
Obesity
Hypertension
Hypertriglyceridemia
Hypercholesterolemia
Weight Loss

Interventions: Other: Healthy Lifestyle

First Posted Date: 2019-04-26

Last Posted Date: 2019-05-08

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 54

Registration Number: NCT03929198

Locations: 🇺🇸
Washington University in St. Louis, Saint Louis, Missouri, United States

Telemedicine Control Tower for the Operating Room: Navigating Information, Care and Safety

Phase 3

Completed

Conditions: Surgery--Complications
Perioperative/Postoperative Complications
Surgery

Interventions: Device: Anesthesia Control Tower monitoring

First Posted Date: 2019-04-23

Last Posted Date: 2024-07-17

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 79560

Registration Number: NCT03923699

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

e-Mindfulness for Depression in Older Adults

Not Applicable

Completed

Conditions: Depression
Mental Health Disorder

Interventions: Behavioral: Mindful My Way

First Posted Date: 2019-04-19

Last Posted Date: 2024-07-24

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 31

Registration Number: NCT03922217

Locations: 🇺🇸
Washington University School of Medicine, Health Mind Lab, Saint Louis, Missouri, United States

Induction Paclitaxel Followed by Concurrent Paclitaxel and Radiation Therapy for Cutaneous Angiosarcoma

Phase 1

Recruiting

Conditions: Cutaneous Angiosarcoma

Interventions: Drug: Paclitaxel
Radiation: Radiation therapy
Procedure: Research blood draw

First Posted Date: 2019-04-19

Last Posted Date: 2024-12-06

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 19

Registration Number: NCT03921008

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Magnetic Resonance-Guided Hypofractionated Adaptive Radiation Therapy With Concurrent Chemotherapy and Consolidation Durvalumab for Inoperable Stage IIB, IIIA, and Select IIIB and IIIC Non-small Cell Lung Cancer

Phase 2

Active, not recruiting

Conditions: Stage IIB Non-Small Cell Lung Cancer
Stage IIIC Non-Small Cell Lung Cancer
Stage IIIA Non-small Cell Lung Cancer
Stage IIIB Non-small Cell Lung Cancer

Interventions: Device: ViewRay MR-Linear Accelerator
Radiation: Radiation therapy
Drug: Paclitaxel
Drug: Carboplatin AUC
Biological: Durvalumab

First Posted Date: 2019-04-16

Last Posted Date: 2024-11-13

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 26

Registration Number: NCT03916419

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Suubi4Cancer: Improving Access to Pediatric Cancer Services and Treatment Adherence Among Children Living With HIV/AIDS

Not Applicable

Withdrawn

Conditions: Cancer
HIV/AIDS

Interventions: Behavioral: Combination intervention

First Posted Date: 2019-04-16

Last Posted Date: 2022-11-09

Lead Sponsor: Washington University School of Medicine

Registration Number: NCT03916783

Locations: 🇺🇬
International Center for Child Health and Development, Masaka, Uganda

Expanded Access Neoantigen Vaccine in Solid Tumors

Conditions: Solid Tumor, Adult

First Posted Date: 2019-04-16

Last Posted Date: 2024-03-12

Lead Sponsor: Washington University School of Medicine

Registration Number: NCT03914872

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Rehabilitation and Quality of Life Assessment for Soft Tissue Sarcoma Treated With Radiotherapy and Surgery

Not Applicable

Terminated

Conditions: Soft Tissue Sarcoma

Interventions: Other: Exercise
Other: Enhanced Recovery after surgery
Other: Psychological screening with counselling services as needed
Other: Dietary Counseling Services

First Posted Date: 2019-04-16

Last Posted Date: 2022-04-12

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 10

Registration Number: NCT03916796

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Optune Device - TT Field Plus Nivolumab and Ipilimumab for Melanoma With Brain Metastasis

Phase 2

Terminated

Conditions: Melanoma With Brain Metastasis

Interventions: Device: Optune
Biological: Nivolumab
Biological: Ipilimumab

First Posted Date: 2019-04-04

Last Posted Date: 2022-06-07

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 2

Registration Number: NCT03903640

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy